Authors:
DINGEMANSE J
WALLNOFER A
GIESCHKE R
GUENTERT T
AMREIN R
Citation: J. Dingemanse et al., PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN FLUOXETINE AND MOCLOBEMIDE IN THE INVESTIGATION OF DEVELOPMENT OF THE SEROTONIN SYNDROME, Clinical pharmacology and therapeutics, 63(4), 1998, pp. 403-413
Citation: R. Gieschke et al., EXPLORING CLINICAL-STUDY DESIGN BY COMPUTER-SIMULATION BASED ON PHARMACOKINETIC PHARMACODYNAMIC MODELING/, International journal of clinical pharmacology and therapeutics, 35(10), 1997, pp. 469-474
Authors:
DINGEMANSE J
GUENTERT T
GIESCHKE R
STABL M
Citation: J. Dingemanse et al., MODIFICATION OF THE CARDIOVASCULAR EFFECTS OF EPHEDRINE BY THE REVERSIBLE MONOAMINE-OXIDASE-A INHIBITOR MOCLOBEMIDE, Journal of cardiovascular pharmacology, 28(6), 1996, pp. 856-861
Authors:
DINGEMANSE J
BURY M
RONCARI G
ZELL M
GIESCHKE R
GAILLARD AWK
ODINK J
VANBRUMMELEN P
Citation: J. Dingemanse et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF RO-41-3696, A NOVEL NONBENZODIAZEPINE HYPNOTIC, Journal of clinical pharmacology, 35(8), 1995, pp. 821-829
Authors:
DINGEMANSE J
JORGA KM
SCHMITT M
GIESCHKE R
FOTTELER B
ZURCHER G
DAPRADA M
VANBRUMMELEN P
Citation: J. Dingemanse et al., INTEGRATED PHARMACOKINETICS AND PHARMACODYNAMICS OF THE NOVEL CATECHOL-O-METHYLTRANSFERASE INHIBITOR TOLCAPONE DURING FIRST ADMINISTRATION TO HUMANS, Clinical pharmacology and therapeutics, 57(5), 1995, pp. 508-517
Authors:
GIESCHKE R
CLUYDTS R
DINGEMANSE J
DEROECK J
DECOCK W
Citation: R. Gieschke et al., EFFECTS OF BRETAZENIL VS ZOLPIDEM AND PLACEBO ON EXPERIMENTALLY-INDUCED SLEEP DISTURBANCE IN HEALTHY-VOLUNTEERS, Methods and findings in experimental and clinical pharmacology, 16(9), 1994, pp. 667-675